Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Condition:   Nasopharyngeal Carcinoma
Intervention:   Drug: Apatinib
Sponsor:   Zhejiang Cancer Hospital
Recruiting - verified July 2017

http://ift.tt/2ueFCTB